Literature DB >> 28251672

Prescribing patterns of analgesics and other medicines by dental practitioners in Australia from 2001 to 2012.

Samantha A Hollingworth1, Ryan Chan2, Jenny Pham2, Sonya Shi2, Pauline J Ford2.   

Abstract

OBJECTIVES: Dental practitioners are able to prescribe a variety of medicines subsidized on the Pharmaceutical Benefits Schedule (PBS), the main categories of which are analgesics and antibiotics. We aimed to investigate the patterns of PBS prescribing of non-antimicrobial medicines by dental practitioners in Australia from 2001 to 2012.
METHODS: Data were collected from Medicare Australia on prescriptions from dental practitioners dispensed to concessional beneficiaries between 2001 and 2012. We examined patterns of use over time.
RESULTS: There was an overall increase in number of prescriptions and in dispensed use (standardized by dose and population) of analgesic medicines for the concessional population over the 12-years period. The use of dentally prescribed analgesics increased 15%, with use of nonsteroidal anti-inflammatory drugs increasing by 41% and opioid analgesics by 12%. Prescribing of the oxycodone 5-mg tablet increased 344% between 2005 and 2012, and dental prescription of the benzodiazepines diazepam and temazepam increased by 51% and 229%, respectively, over the observation period. Injectable corticosteroid use increased by 19%. Conversely, use of carbamazepine and anti-emetics decreased by 39% and 10%, respectively.
CONCLUSIONS: Dental prescribing of analgesics, anti-inflammatories and benzodiazepines in the concessional population has increased significantly over the past decade. These data can form the baseline to further examine appropriate medicine use in the management of dental conditions.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NSAIDs; analgesics; benzodiazepines; dental prescribing; opioids

Mesh:

Substances:

Year:  2017        PMID: 28251672     DOI: 10.1111/cdoe.12291

Source DB:  PubMed          Journal:  Community Dent Oral Epidemiol        ISSN: 0301-5661            Impact factor:   3.383


  8 in total

1.  Rapid Progress toward Elimination of Strongyloidiasis in North Queensland, Tropical Australia, 2000-2018.

Authors:  Matthew Paltridge; Simon Smith; Aileen Traves; Robyn McDermott; Xin Fang; Chris Blake; Brad Milligan; Andrew D'Addona; Josh Hanson
Journal:  Am J Trop Med Hyg       Date:  2020-02       Impact factor: 2.345

2.  Dispensing patterns of emergency medicines prescribed by Australian dentists from 1992 to 2018 - a pharmacoepidemiology study.

Authors:  Joon Soo Park; Estie Kruger; Marc Tennant
Journal:  Int Dent J       Date:  2020-03-13       Impact factor: 2.607

3.  We Should Agree to Disagree.

Authors:  Joon Soo Park; Estie Kruger; Marc Tennant
Journal:  Int Dent J       Date:  2021-02-25       Impact factor: 2.607

4.  A survey of prescribing practices by general dentists in Australia.

Authors:  L Teoh; R J Marino; K Stewart; M J McCullough
Journal:  BMC Oral Health       Date:  2019-08-22       Impact factor: 2.757

5.  Analgesic and Antibiotic Prescription Pattern among Dentists in Guangzhou: A Cross-Sectional Study.

Authors:  Jiali Yu; Er-Min Nie; Rui Jiang; Chun-Yuan Zhang; Xiang Li
Journal:  Pain Res Manag       Date:  2020-12-29       Impact factor: 3.037

6.  Dispensing patterns of medicines prescribed by Australian dentists from 2006 to 2018 - a pharmacoepidemiological study.

Authors:  Joon Soo Park; Amy T Page; Estie Kruger; Marc Tennant
Journal:  Int Dent J       Date:  2020-08-27       Impact factor: 2.607

Review 7.  Is it time US dentistry ended its opioid dependence?

Authors:  Martin H Thornhill; Katie J Suda; Michael J Durkin; Peter B Lockhart
Journal:  J Am Dent Assoc       Date:  2019-10       Impact factor: 3.634

8.  Medication Prescribing Practices in Croatian Dental Offices and Their Contribution to National Consumption.

Authors:  Ivana Šutej; Dragan Lepur; Darko Božić; Katja Pernarić
Journal:  Int Dent J       Date:  2021-02-26       Impact factor: 2.607

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.